• Tue news: 23andMe CEO no longer open to takeover. mRNA vaccines may boost cancer immunotherapy. BMS beats $6.4B lawsuit. CVS Health layoffs and potential breakup. JNJ abandoning proposed 340b plan. See more on our front page

Abbvie HCV


<



We did great launching Mav but Gilead came out with their own generic and now theyre spanking us again. Mav isn’t growing. Gilead has the lions share for what’s left of this diminished market. Micromanagement culture overall how bad depends on what region. If you have an offer somewhere else I’d take it.
 








Similar threads

Replies
2
Views
2K
AbbVie
anonymous
Replies
22
Views
3K
AbbVie
anonymous
Replies
15
Views
2K
AbbVie
Anonymous